Related Experiment Video

Updated: Mar 30, 2026

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
09:01

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 10, 2013

8.4K

Understanding Lung Immunopathology Caused by the Human Metapneumovirus: Implications for Rational Vaccine Design

Christian E Palavecino1, Pablo F Cespedes1, Margarita K Lay1

  • 1Millennium Institute on Immunology and Immunotherapy, Departamento de Genetica Molecular y Microbiologia, Facultad de Ciencias Biologicas, Pontificia Universidad Catolica de Chile, Santiago, Chile.

Critical Reviews in Immunology
|November 13, 2015
PubMed

Insights

Human metapneumovirus (hMPV) causes severe childhood pneumonia and reinfections. Current vaccine strategies in animal models are reviewed to understand immune responses for hMPV clearance and lung inflammation resolution.

Area of Science:

  • Virology
  • Immunology
  • Vaccinology

Background:

  • Acute respiratory tract infections (ARTIs) are a leading cause of global child mortality.
  • Human metapneumovirus (hMPV) is a significant contributor to pediatric pneumonia and hospitalizations.
  • Existing adaptive immune responses to hMPV are insufficient for long-term protection, leading to recurrent infections throughout life.

Purpose of the Study:

  • To review current vaccine strategies against hMPV infection.
  • To analyze findings from animal models regarding immune cell involvement in hMPV clearance.
  • To understand the role of immune cells in preventing and resolving lung inflammation post-hMPV exposure.

Main Methods:

  • Review of published literature on hMPV vaccine strategies.
  • Analysis of studies utilizing animal models to assess immune responses.
  • Examination of data on immune cell populations mediating viral clearance and inflammation control.

Main Results:

  • No licensed vaccines are currently available for hMPV prevention.
  • Various vaccine strategies have been explored in preclinical animal models.
  • Studies highlight the critical role of specific immune cell types in controlling hMPV and mitigating lung pathology.

Conclusions:

  • Understanding host immune responses is crucial for developing effective hMPV vaccines.
  • Animal models provide valuable insights into immune cell functions relevant to hMPV infection.
  • Further research into immune mechanisms may pave the way for novel vaccine development against hMPV.

More Related Videos

Contact-Free Co-Culture Model for the Study of Innate Immune Cell Activation During Respiratory Virus Infection07:36

Contact-Free Co-Culture Model for the Study of Innate Immune Cell Activation During Respiratory Virus Infection

Published on: February 28, 2021

3.6K
Modeling Dysplastic and Functional Lung Alveolar Repair after Influenza Infection07:45

Modeling Dysplastic and Functional Lung Alveolar Repair after Influenza Infection

Published on: September 19, 2025

604

Related Concept Videos

Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
4.1K
Vaccinations01:51

Vaccinations

Overview
53.8K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.3K
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
38
Human Virome01:26

Human Virome

The human body harbors a vast and diverse viral community known as the human virome. The virome includes bacteriophages that infect bacteria, and eukaryotic viruses that infect human cells. Transient dietary and environmental viruses also contribute to this dynamic ecosystem. Estimates suggest the human body may contain on the order of 10¹³ viral particles, though abundance varies widely by body site and detection method.Comprehensive characterization of the virome has become possible...
32
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
2.2K